Health Care & Life Sciences » Pharmaceuticals | Hainan Shuangcheng Pharmaceuticals Co. Ltd.

Hainan Shuangcheng Pharmaceuticals Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
66,771.90
58,932.80
52,679.10
388,410.60
1,329.00
92,148.10
Depreciation, Depletion & Amortization
12,986.20
17,884.80
23,917.10
31,411.80
45,028.70
57,310
Other Funds
-
-
-
26,101.20
192,492.00
24,653.90
Funds from Operations
79,510.60
62,624.70
62,820.90
70,179.40
3,553.40
10,703.70
Changes in Working Capital
10,673.40
11,624.00
27,512.30
108,891.40
38,986.30
60,919.50
Net Operating Cash Flow
68,837.20
51,000.70
35,308.60
38,712.00
35,432.90
50,215.90
Capital Expenditures
65,062.60
115,937.10
289,675.50
182,968.10
69,323.30
Sale of Fixed Assets & Businesses
-
19.60
106.40
1,954.60
689.40
Purchase/Sale of Investments
2,070,560.00
146,021.00
111,370.00
1,630.00
13,750.00
Net Investing Cash Flow
124,062.60
277,068.50
401,592.40
180,465.20
70,483.90
Cash Dividends Paid - Total
44,003.60
36,000.00
27,000.00
-
-
Issuance/Reduction of Debt, Net
-
-
490,000.00
8,309.00
75,000.00
Net Financing Cash Flow
44,003.60
36,000.00
526,934.00
81,726.20
117,492.00
Net Change in Cash
99,214.40
262,364.50
161,399.10
222,378.40
8,178.00
Free Cash Flow
3,774.60
64,936.40
254,366.90
144,256.00
104,756.20
Deferred Taxes & Investment Tax Credit
230.90
644.50
1,707.10
3,121.40
1,751.90
519.40
Other Sources
2,011,560.00
727.90
5,525.00
9,478.20
11,900.00
Change in Capital Stock
-
-
63,934.00
63,934.00
-
Exchange Rate Effect
14.60
296.70
748.80
1,101.00
3,397.20
Other Uses
-
15,857.90
6,178.30
7,300.00
-

About Hainan Shuangcheng Pharmaceuticals Co.

View Profile
Address
No. 16 Xingguo Road
Haikou Hainan 570314
China
Employees -
Website http://www.shuangchengmed.com
Updated 07/08/2019
Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in the manufacture and sale of chemically synthesized peptide drugs & APIs. It offers finished dosages and generic peptide active pharmaceutical ingredient. Its products include Thymalfasin, Levocarnitine, Clindamycin Hydrochloride, Thymopentin, Famotidine and Somatostatin for Injection.